Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study
Author:
Pericot-Valverde Irene1ORCID, Lopes Snehal S2, Nahvi Shadi3, Thrasher James F4, Karasz Alison5ORCID, Taylor Lynn E6, Mehta Shruti H7, Lum Paula J8, Tsui Judith I9, Page Kimberly10ORCID, Feinberg Judith11ORCID, Kim Arthur Y12, Norton Brianna L3, Arnsten Julia H3, Fernandez-Artamendi Sergio13, Heo Moonseong2ORCID, Litwin Alain11415ORCID, Litwin Alain H, Heo Moonseong, Pericot-Valverde Irene, Walker Hagan, Coleman and Ashley, Mehta Shruti H, Borsuk Courtney, Dickerson Brian, Falade-Nwulia Oluwaseun, Fingerhood Michael, Haselhuhn Taryn, Mason Angela, Moon Juhi, Olsen Yngvild, Walters and Vickie, Kim Arthur Y, Roche Jillian M, Schmitt William, Lijewski Virginia, Pitts Anita, Raji Syeda, Silva Taniya, Evans Fiona, Koene Hope, Brown Joelle, Norton Brianna, Agyemang Linda, Arnsten Julia, Karasz Alison, Meissner Paul, Lora Kiara, Hidalgo Jennifer, Soloway Irene, Jefferson Karen, Wong Joyce, Kermack Andrea, Stein Melissa, Joseph Gilian, London Karyn, Allen Lincoln, Marte Venecia, Vera Tatiana, Alvarez and Romy, Mckee M Diane, Lum Paula J, Stein Ellen S, Luetkemeyer Anne F, Cullen Caycee, Gill Gurjot, Tierney Hannah, Shapiro Scott, Azari Soraya, Eveland Joanna, Berrner Daniel, Grey Pauli, Akerley and Jordan, Page Kimberly, Wagner Katherine, Davis Herbert, Murray-Krezan Cristina, Jacobsohn Vanessa, Anderson Jessica, Taylor Lynn E, Tashima Karen, Sprecht-Walsh Sophie, Thomas Aurielle, Hordes Melissa, McGregor Danielle, Duryea Patrick, Weenig and Kathryn, Tsui Judith I, Blalock Kendra L, Kim Hyang Nina, Ramchandani Meena S, James Jocelyn R, Peavy K Michelle, Grekin Paul, Ninburg and Michael, Feinberg Judith, Wilkinson Samuel, Thomas Danielle, Kelley Lacey, Calkins Andrea, Henry Gabrielle,
Affiliation:
1. Department of Psychology, Clemson University , Clemson, South Carolina , USA 2. Department of Public Health Sciences, Clemson University , Clemson, South Carolina , USA 3. Department of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine , Bronx, New York , USA 4. Department of Health Promotion, Education, and Behavior, Arnold School of Public Health, University of South Carolina , Columbia, South Carolina , USA 5. Department of Family Medicine & Community Health, University of Massachusetts , Worcester, Massachusetts , USA 6. College of Pharmacy, University of Rhode Island . Kingston, Rhode Island , USA 7. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland , USA 8. Department of Medicine, University of California , San Francisco, San Francisco, California , USA 9. Division of General Internal Medicine, University of Washington , Seattle, Washington , USA 10. Department of Internal Medicine, University of New Mexico Health Sciences Center , Albuquerque, New Mexico , USA 11. Department of Behavioral Medicine & Psychiatry and Department of Medicine, Infectious Diseases, West Virginia University School of Medicine , Morgantown, West Virginia , USA 12. Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts , USA 13. Department of Personality, Assessment, and Psychological Treatment, Universidad de Sevilla , Seville , Spain 14. Department of Medicine, University of South Carolina School of Medicine , Greenville, South Carolina , USA 15. Department of Medicine, Prisma Health , Greenville, South Carolina , USA
Abstract
Abstract
Background
Depressive symptoms are prevalent among people who inject drugs (PWID) and people with hepatitis C virus (HCV). We examined changes in depressive symptoms among HCV-infected PWID following direct-acting antiviral treatments to evaluate whether these changes differed by history of depressive symptoms, substance use, or HCV treatment outcome.
Methods
We conducted a secondary analysis of the HERO Study (NCT02824640), a pragmatic randomized clinical trial among PWID, to test the effectiveness of HCV care models. Depressive symptoms (primary outcome) were measured using the Patient Health Questionnaire (PHQ-9) at baseline, end of treatment (EOT), and at follow-up 12 and 24 weeks after EOT. Sustained virologic response (SVR) was defined as undetectable HCV RNA at ≥12 weeks following EOT. Baseline drug use was defined as having a positive urine screening test for amphetamine, methamphetamine, benzodiazepine, cocaine, cannabis, opiate, or oxycodone.
Results
The sample (n = 498) was 72.3% male, 64.2% White, and on average 43.9 years old. In patients who achieved SVR (F(3432) = 4.58; P = .004) and those with drug use at baseline (F(3478) = 5.11; P < .01), PHQ-9 scores significantly declined over time, with scores lower at EOT and both follow-ups as compared with baseline. Mean PHQ-9 scores at EOT and follow-ups were significantly lower than at baseline, except for those with no depression or mild depression at baseline.
Conclusions
This study showed that HCV treatment in PWID is associated with sustained declines in depression up to 24 weeks post-treatment among those who achieve SVR and that drug use does not interfere with improvement in depressive symptoms.
Funder
Patient-Centered Outcomes Research Institute Gilead Sciences Quest Diagnostics Monogram Biosciences OraSure Technologies
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Oncology
Reference18 articles.
1. Prevalence of psychiatric disorders among young injection drug users;Mackesy-Amiti;Drug Alcohol Depend,2012 2. Depression, post-traumatic stress disorder, suicidality and self-harm among people who inject drugs: a systematic review and meta-analysis;Colledge;Drug Alcohol Depend,2020 3. Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1–6 receiving opioid substitution therapy;Grebely;Int J Drug Policy,2019 4. Depression, anxiety, and stress among people with chronic hepatitis C virus infection and a history of injecting drug use in New South Wales, Australia;Fortier;J Addict Med,2017 5. Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder;Hauser;Psychosomatics,2009
|
|